SVB Leerink Begins Coverage on United Therapeutics (NASDAQ:UTHR)

SVB Leerink started coverage on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a research note published on Monday, Marketbeat reports. The firm issued an outperform rating and a $330.00 price target on the biotechnology company’s stock. A number of other equities research analysts have also recently commented on UTHR. StockNews.com cut shares of […]

Leave a Reply

Your email address will not be published.

Previous post Barclays Increases AbbVie (NYSE:ABBV) Price Target to $185.00
Next post Griffon (NYSE:GFF) Given New $75.00 Price Target at Raymond James